 |
|
Vitamin B does not slow cognitive decline in Alzheimer's
October 15, 2008A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease. The study will be published in the October 15 issue of the Journal of the American Medical Association (JAMA).
Aisen is director of the Alzheimer's Disease Cooperative Study (ADCS), a multi-center network spanning the United States and Canada, which conducted the clinical trial to determine if reduction of an amino acid called homocysteine would reduce the risk of Alzheimer's disease or slow its progression. Homocysteine is known to be involved in neurological disease, including Alzheimer's, and its metabolism is affected by B vitamins. Therefore, it was thought that B vitamin supplements might offer a new therapeutic approach in treating Alzheimer' disease.
"Prior studies using B vitamin supplementation to reduce homocysteine levels in patients with Alzheimer's weren't large enough, or of long enough duration to effectively assess their impact on cognitive decline," said Aisen. "This study of several hundred individuals over the course of 18 months showed no impact on cognition, although it resulted in lower levels of homocysteine in these patients."
The study included supplementation with folic acid and vitamins B6 and B12 for 18 months in 409 individuals with mild to moderate Alzheimer's disease. Participants were randomly assigned to two groups of unequal size; to increase enrollment, 60 percent were treated with high-dose supplements and the remaining 40 percent treated with identical dosages of placebo. A total of 340 participants (202 in active treatment group and 138 in placebo group) completed the trial while taking study medication. Cognitive abilities were measured via testing with the Alzheimer Disease Assessment Scale (ADAS-cog).
The researchers found that the ADAS-cog score did not differ significantly between treatment groups, but that symptoms of depression were more common in the high-dose supplement group.
"Our study does not support the treatment of individuals with mild to moderate Alzheimer's disease and normal vitamin levels with B vitamin supplements," the authors conclude.
University of California - San Diego
The study included supplementation with folic acid and vitamins B6 and B12 for 18 months in 409 individuals with mild to moderate Alzheimer's disease. Participants were randomly assigned to two groups of unequal size; to increase enrollment, 60 percent were treated with high-dose supplements and the remaining 40 percent treated with identical dosages of placebo. A total of 340 participants (202 in active treatment group and 138 in placebo group) completed the trial while taking study medication. Cognitive abilities were measured via testing with the Alzheimer Disease Assessment Scale (ADAS-cog).
The researchers found that the ADAS-cog score did not differ significantly between treatment groups, but that symptoms of depression were more common in the high-dose supplement group.
"Our study does not support the treatment of individuals with mild to moderate Alzheimer's disease and normal vitamin levels with B vitamin supplements," the authors conclude.
University of California - San Diego
Cognitive Decline Current Events and Cognitive Decline News RSSSurgery not linked to memory problems in older patients
For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions.
Cognitive dysfunction reversed in mouse model of Down syndrome
A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome.
Researchers find potential treatment for Huntington's disease
Investigators at Burnham Institute for Medical Research (Burnham), the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington's disease.
Reduced muscle strength associated with risk for Alzheimer's
Individuals with weaker muscles appear to have a higher risk for Alzheimer's disease and declines in cognitive function over time, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.
APP -- Good, bad or both?
New data about amyloid precursor protein, or APP, a protein implicated in development of Alzheimer's disease, suggests it also may have a positive role -- directly affecting learning and memory during brain development.
Declines in other thinking and learning skills may precede memory loss in Alzheimer's disease
Cognitive abilities other than memory, including visuospatial skills needed to perceive relationships between objects, may decline years prior to a clinical diagnosis in patients with Alzheimer's disease, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.
Alcoholism's effect on sleep persists during long periods of sobriety
A study in the Oct.1 issue of the journal Sleep shows that long-term alcoholism affects sleep even after long periods of abstinence, and the pattern of this effect is similar in both men and women.
Impaired kidney function linked to cognitive decline in elderly
A new study published in the medical journal Neurology suggests that impaired kidney function is a risk factor for cognitive decline in old age.
Mount Sinai researchers find phone assessment effective for evaluating cognition in the elderly
Cognitive testing by telephone in elderly individuals is generally as effective as in-person testing, according to a new study by Effie M. Mitsis, PhD, Assistant Professor of Psychiatry at Mount Sinai School of Medicine and part of Mount Sinai's Alzheimer's Disease Research Center. The study will appear in the International Journal of Geriatric Psychiatry.
Infections may lead to faster memory loss in Alzheimer's disease
Getting a cold, stomach bug or other infection may lead to increased memory loss in people with Alzheimer's disease.
More Cognitive Decline Current Events and Cognitive Decline News Articles
 |
Cognitive Decline: Strategies for Prevention by H. M. Fillit (Editor), R. N. Butler (Editor) Cognitive Decline - Strategies for Prevention examines the problems associated with our understanding of the ageing brain, whether or not such decline is inevitable and if there are practical steps which can be taken to prevent or minimise cognitive decline in late life. Preventive medical strategies have primarily targeted the top three causes of death in the developed world: heart disease, cancer and stroke. Less attention to date has been paid to cognitive decline and dementia, possible because the generally held view has been that little of nothing could be done to help them. Our knowledge has grown rapidly and it is becoming clear that preventative strategies are now viable. Cognitive Decline - Strategies for Prevention brings together a group of leading researchers to assess and... |
 |
Brain Fitness by HAPPYneuron, Inc. Brain vitality and agility is vital for success in daily life for everyone, whether you are a student, professional, a stay at home mom or are retired. This Brain Fitness CD ROM contains fun and innovative exercises and tools that will provide your brain with a full mental workout. Your brain requires novel and complex stimulation to build brainpower. This program provides just that! In just 20 minutes per day, Brain Fitness will help increase thinking ability, prevent brain aging, and hone all five cognitive functions of memory, language, concentration, visual spatial skills and executive function. Moreover, it will provide you with the tools to monitor and track your progress. All your brain needs to stay fit for life! |
 |
Cognitive Decline Jesse Zubot (Primary Contributor) |
 |
Cognitive Changes with Aging: What Can You Expect? This lecture focuses on memory problems people face and their correlation to problems later in life. Also discussed: when is testing appropriate, benefits of early testing, what the tests involve and what they mean, decision-making and cognition, and appropriate interventions. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
AD-Focus-60 tablets: Treats ADD and ADHD, The Common Mental Health and Behavioral Disorders in Children. by Biospec The Most Common Mental Health Disorder and Behavioral Disorder in Children Is ADD and ADHD; Half of these Children Carry ADHD into Adulthood! ADHDs Life Altering Symptoms: Restless, Behavioral Disorder, Unable to Focus, Easily Distracted, Forgetful,Mood Swings, Tantrums, Impulsivity, Slow Completing Tasks, Disorganized, Sensitive to Stress. Worse Yet: 40% with ADHD have learning disabilities and 50% have neurological disorders; MotorTic Disorder or Tourettes Disorder, Anxiety Disorder, Anger Control Problems and Depression. Why Should You Treat ADHD Nutritionally? Refined foods low in vital nutrients and the exposure to toxic chemicals in our environment leads to systemic inflammation, oxidative stress and insulin resistance that are associated with brain dysfunction. BIOSPECs AD-Focus:... |
|
Neurofeedback--brain training for mental ills: biofeedback techniques show promise in treating such conditions as epilepsy, addiction, and cognitive decline.: An article from: Mind, Mood & Memory by Gale Reference Team (Author) This digital document is an article from Mind, Mood & Memory, published by Thomson Gale on December 1, 2006. The length of the article is 656 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Neurofeedback--brain training for mental ills: biofeedback techniques show promise in treating such conditions as epilepsy, addiction, and cognitive decline. Author: Gale Reference Team Publication: Mind, Mood & Memory (Magazine/Journal) Date: December 1, 2006 Publisher: Thomson Gale Volume: 2 Issue: 12 Page: 3(1) Distributed by Thomson... | |
|
Screen for cognitive decline at all stages of HIV. (Impairment may Predict Mortality).: An article from: Clinical Psychiatry News by Damian McNamara (Author) This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on June 1, 2003. The length of the article is 956 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Screen for cognitive decline at all stages of HIV. (Impairment may Predict Mortality). Author: Damian McNamara Publication: Clinical Psychiatry News (Magazine/Journal) Date: June 1, 2003 Publisher: International Medical News Group Volume: 31 Issue: 6 Page: 26(1) Distributed by Thomson... | |
 |
Posit Science Brain Fitness Program & InSight Bundle for Two People, PC Version by Posit Science Corporation Work Out More of Your Brain The InSight and Brain Fitness Bundle contains both Posit Science training programs packaged together to help you save money. Using both programs engages more of the brain and maximizes brain fitness. The Brain Fitness Program works out auditory processing and memory. Use it to: Remember more of what you hear InSight works out visual processing and memory. It helps you: Drive more safely and cut your car crash risk by 50% |
|
Myelination defects may play key role in schizophrenia. (Cognitive Decline in Later Life).: An article from: Clinical Psychiatry News by Carl Sherman (Author) This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on February 1, 2003. The length of the article is 562 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Myelination defects may play key role in schizophrenia. (Cognitive Decline in Later Life). Author: Carl Sherman Publication: Clinical Psychiatry News (Magazine/Journal) Date: February 1, 2003 Publisher: International Medical News Group Volume: 31 Issue: 2 Page: 57(1) Distributed by Thomson... | |
|
Estrogens not protective against cognitive decline: patients with or without dementia. (Women's Health).: An article from: Family Practice News by Jeff Evans (Author) This digital document is an article from Family Practice News, published by International Medical News Group on May 15, 2003. The length of the article is 581 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Estrogens not protective against cognitive decline: patients with or without dementia. (Women's Health). Author: Jeff Evans Publication: Family Practice News (Magazine/Journal) Date: May 15, 2003 Publisher: International Medical News Group Volume: 33 Issue: 10 Page: 33(1) Distributed by Thomson... |
| © 2009 BrightSurf.com |